Thursday, February 21, 2013

• Webcast Alert: Isis Pharmaceuticals' 2012 Financial Results and Highlights Conference CallPR Newswire (Thu, Feb 21)

Wednesday, February 20, 2013

• Bernstein Liebhard LLP Announces That Only Six Days Remain To File A Motion For Lead Plaintiff In A Class Action Against Isis Pharmaceuticals, Inc.PR Newswire (Wed, Feb 20)

Tuesday, February 19, 2013

• 4 Healthcare Stock Stories for Tuesday Wellnessat Wall St. Cheat Sheet (Tue, Feb 19)
• Will Isis Right Pfizer's Wrong?at Motley Fool (Tue, Feb 19)
• Isis Initates Phase 2/3 Study Of ISIS-TTR Rx And Earns $7.5 Million Milestone Payment From GlaxoSmithKlinePR Newswire (Tue, Feb 19)

Wednesday, February 13, 2013

• ISIS PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal OfficersEDGAR Online (Wed, Feb 13)

Sunday, February 10, 2013

• How Long Can This Pharma Gold Rush Last?at Motley Fool (Sun, Feb 10)

Thursday, February 7, 2013

• Sanofi CEO: It's Not A Plavix Hangover, We're Investing In Launching New Drugsat Forbes (Thu, Feb 7)
• Isis Pharmaceuticals to Present at the 2013 Leerink Swann Global Healthcare ConferencePR Newswire (Thu, Feb 7)

Tuesday, February 5, 2013

• Levi & Korsinsky Notifies Investors With Losses on Their Investment in Isis Pharmaceuticals, Inc. of Class Action Lawsuit and the Deadline of February 26, 2013 to Seek a Lead Plaintiff PositionMarketwired (Tue, Feb 5)

Monday, February 4, 2013

• Sanofi & Isis Out-Limbo Aegerion in HoFHat Motley Fool (Mon, Feb 4)

Friday, February 1, 2013

• Isis: FDA Approval Of Kynamro Promises A Bright Future For Companyat Seeking Alpha (Fri, Feb 1)
• Number of FDA Drug Approvals Reach a 15-Year High in 2012Marketwired (Fri, Feb 1)

Thursday, January 31, 2013

• Who Will Win This Small Drug Market?at Motley Fool (Thu, Jan 31)
• Mipomersen Approved, Bonus Antisense Roundup Includedat Seeking Alpha (Thu, Jan 31)
• Yum! Improves SSS in China and 4 Stock Analyses Making Roundsat Wall St. Cheat Sheet (Thu, Jan 31)
• Zacks Bull and Bear of the Day Highlights: Smithfield Foods, Logitech International, Sanofi, Isis Pharmaceuticals and Aegerion PharmaceuticalsZacks (Thu, Jan 31)
• 4 Stocks Rising on Big Volumeat TheStreet (Thu, Jan 31)

Wednesday, January 30, 2013

• FDA Approves Genzyme, Isis's Kynamroat Motley Fool (Wed, Jan 30)
• Isis Aces its Testat Motley Fool (Wed, Jan 30)
• 4 Healthcare Stock Stories for Wednesday Wellnessat Wall St. Cheat Sheet (Wed, Jan 30)
• Isis Jumps as FDA Clears Cholesterol Treatmentat Bloomberg (Wed, Jan 30)
• US Nod for ISIS/Sanofi's KynamroZacks (Wed, Jan 30)
• Why Isis Pharmaceuticals Shares Poppedat Motley Fool (Wed, Jan 30)
• Isis Pharmaceuticals' CEO Discusses Update on FDA Approval of KYNAMRO Conference Call (Transcript)at Seeking Alpha (Wed, Jan 30)

Add ISIS News to My Yahoo!